In cancer treatment, precision medicine refers to targeted therapy based on biomarkers, including proteins and genes: for example, EGFR in lung cancer [28] and BRCA1/2 in ovarian cancer [16]. This evidence concerns the gene BRCA1 and ovarian cancer.